Adaptimmune Therapeutics shares owned by Marshall Wace
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Marshall Wace
from 13F filings
Historical chart of Marshall Wace investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Marshall Wace
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $286k | 529k | 0.54 |
| 2024-09-30 | $497k | 523k | 0.95 |
| 2024-06-30 | $141k | 145k | 0.97 |
| 2024-03-31 | $401k | 254k | 1.58 |
| 2023-06-30 | $254k | 273k | 0.93 |
| 2022-12-31 | $130k | 89k | 1.46 |
| 2021-12-31 | $2.1M | 568k | 3.75 |
| 2021-09-30 | $8.0M | 1.6M | 5.17 |
| 2020-06-30 | $3.8M | 376k | 10.01 |
| 2019-12-31 | $35k | 29k | 1.20 |
| 2019-09-30 | $120k | 79k | 1.51 |
| 2018-12-31 | $748k | 130k | 5.75 |
| 2015-12-31 | $1.7M | 141k | 12.06 |